Kovitz Investment Group Partners’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$725K Sell
16,990
-46,410
-73% -$2.52M 0.02% 354
2026
Q1
$3.98M Sell
63,400
-167,170
-73% -$13.4M 0.09% 151
2025
Q4
$22M Sell
230,570
-1,544
-0.7% -$151K 0.49% 47
2025
Q3
$22.7M Buy
232,114
+157,440
+211% +$16.3M 0.09% 202
2025
Q2
$8.02M Buy
74,674
+39,608
+113% +$4.01M 0.03% 353
2025
Q1
$3.54M Buy
35,066
+14,759
+73% +$1.49M 0.02% 469
2024
Q4
$1.81M Buy
20,307
+794
+4% +$69.9K 0.01% 592
2024
Q3
$286K Buy
+19,513
New +$1.54M ﹤0.01% 883

Other funds holding BSX

Kovitz Investment Group Partners's BSX Position: Q2 2026 in Review

Kovitz Investment Group Partners reduced its Boston Scientific (BSX) stake by 73% in Q2 2026, selling an estimated $2.52M and leaving 16,990 shares worth $725K. The position accounts for 0.02% of the portfolio, ranked #354.

Kovitz Investment Group Partners first reported a position in BSX in Q3 2024 and has held it in 8 quarters since. The position peaked at $22.7M in Q3 2025. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Kovitz Investment Group Partners held 16,990 shares of Boston Scientific worth $725K as of Q2 2026.
  • Kovitz Investment Group Partners sold 46,410 Boston Scientific shares in Q2 2026, an estimated $2.52M.
  • Boston Scientific made up 0.02% of Kovitz Investment Group Partners's portfolio in Q2 2026, its #354 holding.
  • Kovitz Investment Group Partners first reported a position in Boston Scientific in Q3 2024 and has held it in 8 quarters since.
  • Kovitz Investment Group Partners's Boston Scientific position peaked at $22.7M in Q3 2025.
  • 1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Kovitz Investment Group Partners's 13F filing for Q2 2026, filed 12 Aug 2026.